3

FORM 3 SUBMISSION

Company: Eledon Pharmaceuticals, Inc.
Filed: May 11, 2017
Period of Report: May 10, 2017
Accession Number: 0000899243-17-012924

View Document ↗ View on SEC.gov ↗